Results 221 to 230 of about 29,480 (254)
Pharmacological inhibition of PERK in a DEN‐induced mouse model of liver cancer does not reduce tumor burden but alters cellular stress signaling. Despite blocking PERK activity, downstream stress responses, including CHOP expression, remain active, suggesting compensatory mechanisms within the unfolded protein response that may influence tumor ...
Ada Lerma‐Clavero +5 more
wiley +1 more source
UNICORN and the Evolution of Coronary Protection in the Redo-TAVR Era. [PDF]
Song GY.
europepmc +1 more source
Treatment of oligometastatic lung cancers: new data, new drivers, new approaches. [PDF]
O'Dwyer N, Palma DA.
europepmc +1 more source
Carotid Artery Stenting: Evolution, Evidence, and Contemporary Practice in the Era of Intensive Medical Therapy. [PDF]
Dixit S +10 more
europepmc +1 more source
Bibliometric and trend analysis of the top 100 most-cited articles on anterior lumbar interbody fusion (ALIF). [PDF]
Hafiz B +8 more
europepmc +1 more source
Reconfiguring agency under platform governance: Baby Boomer and Generation X singers negotiating identity, algorithms, and monetization. [PDF]
Hastuti A, Widodo S, Suhariadi F.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
Expert Review of Respiratory Medicine, 2016Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease with a fatal prognosis. Over the last decade, the concepts in pathobiology of pulmonary fibrosis have shifted from a model of chronic inflammation to dysregulated fibroproliferative repair in genetically predisposed patients.
Ganesh Raghu
exaly +3 more sources

